ARYYX
Price
$14.58
Change
+$0.02 (+0.14%)
Updated
Jun 5 closing price
Net Assets
798.7M
CSFAX
Price
$58.14
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
2.31B
Interact to see
Advertisement

ARYYX vs CSFAX

Header iconARYYX vs CSFAX Comparison
Open Charts ARYYX vs CSFAXBanner chart's image
ARYYX vs CSFAX Comparison Chart in %
View a ticker or compare two or three
VS
ARYYX vs. CSFAX commentary
Jun 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARYYX is a Buy and CSFAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSFAX has more cash in the bank: 2.32B vs. ARYYX (799M). ARYYX pays higher dividends than CSFAX: ARYYX (3.10) vs CSFAX (2.94). ARYYX was incepted earlier than CSFAX: ARYYX (9 years) vs CSFAX (22 years). CSFAX (1.19) is less costly to investors than ARYYX (0.76). ARYYX is a more actively managed with annual turnover of: 137.00 vs. CSFAX (57.00). ARYYX (0) and CSFAX (0) have matching initial minimum investment requirements. ARYYX annual gain was more profitable for investors over the last year : 13.69 vs. CSFAX (11.38). ARYYX return over 5 years is better than : 10.83 vs. CSFAX (5.63).
ARYYXCSFAXARYYX / CSFAX
Total Expense Ratio0.761.1964%
Annual Report Gross Expense Ratio0.761.1964%
Fund Existence9 years22 years-
Gain YTD8.7387.190122%
Front LoadN/A5%-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets799M2.32B35%
Annual Yield % from dividends3.102.94105%
Returns for 1 year13.6911.38120%
Returns for 3 years38.4227.76138%
Returns for 5 years10.835.63192%
Returns for 10 yearsN/A48.15-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ODINX107.36N/A
N/A
Invesco Discovery R
AIEMX16.49N/A
N/A
Alger Emerging Markets I
HGHCX25.05N/A
N/A
Hartford Healthcare C
JMVCX16.43N/A
N/A
Janus Henderson Mid Cap Value C
DFDMX33.07-0.37
-1.11%
DF Dent Midcap Growth Investor